Table 1.
Phenotype | T2D (n) | ND (n) | p-value |
---|---|---|---|
Age, years | 52.13 ± 9.15 (92) | 43.3 ± 12.782 (96) | <0.001 |
Gender (F/M) | 43/49 | 69/27 | 0.143 |
Height, m | 1.65 ± 0.08 (91) | 1.63 ± 0.10 (96) | 0.073 |
Weight, Kg | 87.06 ± 14.82 (91) | 78.36 ± 18.78 (96) | 0.001 |
BMI, Kg/m2 | 31.60 ± 4.32 (92) | 29.26 ± 5.36 (96) | 0.001 |
WHR | 0.96 ± 0.19 (64) | 0.85 ± 0.09 (67) | <0.001 |
FPG, mmol/L | 8.35 ± 3.03 (91) | 5.30 ± 0.82 (94) | <0.001 |
HbA1c, % | 7.75 ± 1.84 (90) | 5.58 ± 0.50 (92) | <0.001 |
Total Cholesterol, mmol/L | 4.96 ± 1.35 (90) | 5.20 ± 0.94 (95) | 0.158 |
HDL, mmol/L | 1.19 ± 0.48 (89) | 1.41 ± 0.41 (95) | 0.001 |
LDL, mmol/L | 3.08 ± 1.15 (88) | 3.27 ± 0.87 (95) | 0.226 |
TGL, mmol/L | 1.63 ± 1.20 (90) | 1.13 ± 0.67 (94) | 0.001 |
Insulin, U/L | 14.86 ± 10.02 (70) | 9.70 ± 5.44 (57) | <0.001 |
Unless otherwise specified, data are presented as mean ± SD. p-Values were calculated using Student’s T-test and Fisher’s Exact test BMI, body mass index; F/M, female/male; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; n, number of subjects with available measurements; ND, non-diabetic; T2D, Type 2 diabetes; TGL, triglycerides; WHR, waist-to-hip ratio. Statistically significant p-values are in bold font.